Dual-protection Brucella vaccine covering tuberculosis
This technology is a dual-purpose vaccine designed to protect against both Brucella and Tuberculosis (TB) infections simultaneously. It uses a modified, safe strain of Brucella bacteria as a delivery vehicle to carry and express specific proteins from the TB bacteria. By optimizing the genetic code of the TB proteins to match the host Brucella strain, the vaccine triggers a more effective immune response against both diseases in a single dose.
What you could build
A multivalent veterinary or human vaccine sold to livestock producers, government public health agencies, or global health organizations to reduce the cost and complexity of disease prevention programs.
Who in Virginia should care
Virginia's significant agricultural sector, specifically cattle farming, and the presence of global health biopharmaceutical companies like those in the Richmond-to-DC corridor would find value in zoonotic disease prevention.
Readiness: Lab validated
Concept — described but not yet demonstrated. Lab validated — supported by experimental results in the patent. Prototype likely — the text describes a built, working embodiment.
Readiness is inferred from the patent text, not from a lab visit.
The record
- Inventors
- —
- Granted
- September 10, 2019
- Status
- Granted patent
- Patent number
- 102818
Ready to talk?
Virginia Tech Intellectual Properties handles licensing for this technology.
Prosim summaries are generated from public patent text and are not legal advice.